Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cynosure is a global leader in the development and commercialization of light-based aesthetic and medical devices. Its products are widely used by dermatologists, plastic surgeons, gynecologists, and other practitioners for noninvasive procedures such as hair removal, skin rejuvenation/revitalization, scar/tattoo/vascular/pigment lesion treatments, fat/cellulite reduction/body contouring. The company has over three decades of experience in the field with more than $330 million in annual revenue prior to its merger with Lutronic in January 2024. It holds at least 62 patents related to laser medicine and photonics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cynosure.